These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 12955385)
1. Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats. Muñoz A; Lopez-Real A; Labandeira-Garcia JL; Guerra MJ Exp Brain Res; 2003 Nov; 153(1):92-9. PubMed ID: 12955385 [TBL] [Abstract][Full Text] [Related]
2. Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses. Muñoz A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL Synapse; 2003 Jan; 47(1):66-76. PubMed ID: 12422375 [TBL] [Abstract][Full Text] [Related]
3. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733 [TBL] [Abstract][Full Text] [Related]
4. The corticostriatal system mediates the "paradoxical" contraversive rotation but not the striatal hyperexpression of Fos induced by amphetamine early after 6-hydroxydopamine lesion of the nigrostriatal pathway. Lopez-Martin E; Rozas G; Rodriguez J; Guerra MJ; Labandeira-Garcia JL Exp Brain Res; 1998 May; 120(2):153-63. PubMed ID: 9629957 [TBL] [Abstract][Full Text] [Related]
5. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons. Guerra MJ; Liste I; Labandeira-Garcia JL Synapse; 1998 Jan; 28(1):71-82. PubMed ID: 9414020 [TBL] [Abstract][Full Text] [Related]
6. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression. Labandeira-Garcia JL; Rozas G; Lopez-Martin E; Liste I; Guerra MJ Exp Brain Res; 1996 Feb; 108(1):69-84. PubMed ID: 8721156 [TBL] [Abstract][Full Text] [Related]
7. Phenotype of striatal cells expressing c-Fos following amphetamine treatment of rats with intrastriatal dopaminergic grafts. Abrous DN; Bernard V; Le Moal M; Bloch B; Herman JP Eur J Neurosci; 1996 Dec; 8(12):2521-9. PubMed ID: 8996801 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice. Villégier AS; Drouin C; Bizot JC; Marien M; Glowinski J; Colpaërt F; Tassin JP Synapse; 2003 Dec; 50(4):277-84. PubMed ID: 14556232 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum. Lopez A; Muñoz A; Guerra MJ; Labandeira-Garcia JL Neuroscience; 2001; 103(3):639-51. PubMed ID: 11274784 [TBL] [Abstract][Full Text] [Related]
10. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine. Genova LM; Hyman SE Synapse; 1998 Sep; 30(1):71-8. PubMed ID: 9704883 [TBL] [Abstract][Full Text] [Related]
11. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. Berretta S; Robertson HA; Graybiel AM J Neurophysiol; 1992 Sep; 68(3):767-77. PubMed ID: 1359024 [TBL] [Abstract][Full Text] [Related]
12. Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. Gardier AM; Moratalla R; Cuéllar B; Sacerdote M; Guibert B; Lebrec H; Graybiel AM J Neurochem; 2000 Apr; 74(4):1363-73. PubMed ID: 10737591 [TBL] [Abstract][Full Text] [Related]
13. Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Mandel RJ; Leanza G; Nilsson OG; Rosengren E Brain Res; 1994 Aug; 653(1-2):57-65. PubMed ID: 7982076 [TBL] [Abstract][Full Text] [Related]
14. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? Isacson R; Kull B; Wahlestedt C; Salmi P Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337 [TBL] [Abstract][Full Text] [Related]
15. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. Kusljic S; Copolov DL; van den Buuse M Neuropsychopharmacology; 2003 Dec; 28(12):2138-47. PubMed ID: 12888784 [TBL] [Abstract][Full Text] [Related]
16. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510 [TBL] [Abstract][Full Text] [Related]
17. Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons. Rodriguez-Pallares J; Parga JA; Rey P; Guerra MJ; Labandeira-Garcia JL Synapse; 2005 Oct; 58(1):13-22. PubMed ID: 16037947 [TBL] [Abstract][Full Text] [Related]
18. Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Lanteri C; Salomon L; Torrens Y; Glowinski J; Tassin JP Neuropsychopharmacology; 2008 Jun; 33(7):1724-34. PubMed ID: 17805311 [TBL] [Abstract][Full Text] [Related]
19. Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats. Kusljic S; van den Buuse M; Gogos A J Integr Neurosci; 2022 Jan; 21(1):17. PubMed ID: 35164453 [TBL] [Abstract][Full Text] [Related]
20. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats. Sawynok J; Reid A J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]